According to the most recent financial data from March 2025, the current EPS (TTM) is $25.8. Elevance Health's EPS for 2024 came in at $25.81, marking an increase from $25.38 in 2023. For the quarterly period ending on Mar 31, 2025, ELV's EPS was $9.64.
Elevance Health had an annual EPS of $25.81, marking an increase of 1.7% from $25.38 in 2023. The quarterly EPS for the period ending Mar 31, 2025, was $9.64, marking a 0.1% decrease from the same quarter last year. ELV's TTM EPS stands at $25.8 as of March 2025. Elevance Health's EPS for 2023 stood at $25.38, a 3.3% increase from 2022.
Over the last 12 months, Elevance Health has registered an EPS growth of -0.1% (YoY, quarterly). Looking at a longer timeframe, the company recorded an average EPS growth rate of 0.7% per year over the past 3 years. Over the last 5 years, the company had an average EPS growth rate of 6.5%. A 10-year view shows that ELV has seen an average EPS growth of 10.7% per year.
Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
---|---|---|---|---|
ELV Elevance Health Inc | 14.91 | 1.7% | 0.7% | 6.5% |
PFG Principal Financial Group Inc | 16.18 | 162.4% | 4.9% | 6.2% |
OSCR Oscar Health Inc | 29.06 | 109% | N/A | N/A |
LIFW MSP Recovery Inc | N/A | -110.7% | N/A | N/A |
NEUE NeueHealth Inc. | N/A | 85% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.